About the Authors
- Fei Wu
-
Contributed equally to this work with: Fei Wu, Dan Huang
Affiliation Institut Mérieux Laboratory, Fudan University Shanghai Cancer Center, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China
- Dan Huang
-
Contributed equally to this work with: Fei Wu, Dan Huang
Affiliations Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, Institutes of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China
- Lisha Wang
-
Affiliations Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, Institutes of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China
- Qinghua Xu
-
Affiliation Institut Mérieux Laboratory, Fudan University Shanghai Cancer Center, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China
- Fang Liu
-
Affiliation Institut Mérieux Laboratory, Fudan University Shanghai Cancer Center, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China
- Xun Ye
-
Affiliation Institut Mérieux Laboratory, Fudan University Shanghai Cancer Center, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China
- Xia Meng
-
Affiliation Institut Mérieux Laboratory, Fudan University Shanghai Cancer Center, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China
- Xiang Du
-
* E-mail: dx2008cn@yahoo.com.cn
Affiliations Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, Institutes of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China
Competing Interests
The authors have the following interest: FW, QX, FL, XY and XM are the employees of bioMérieux company. THEROS CancerTYPE ID is marketed by bioMérieux. There are no patents or other products in development to declare. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: XM XD. Performed the experiments: FW DH LW. Analyzed the data: FW. Contributed reagents/materials/analysis tools: FL XY DH. Wrote the paper: FW QX XM.